Veracyte, Inc. Files 8-K on Financials

Ticker: VCYT · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1384101

Veracyte, Inc. 8-K Filing Summary
FieldDetail
CompanyVeracyte, Inc. (VCYT)
Form Type8-K
Filed DateAug 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, operations, sec-filing

Related Tickers: VCYT

TL;DR

VCYT filed an 8-K on Aug 6, 2025, updating on financials. Details pending.

AI Summary

On August 6, 2025, Veracyte, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, as well as financial statements and exhibits. No specific financial figures or operational details were disclosed in the provided excerpt.

Why It Matters

This 8-K filing indicates Veracyte, Inc. is providing updates on its financial condition and operations to the SEC, which is important for investors to monitor the company's performance.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report for operational and financial updates, with no immediate indication of significant negative events.

Key Players & Entities

  • VERACYTE, INC. (company) — Registrant
  • August 6, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • 6000 Shoreline Court, Suite 300, South San Francisco, California 94080 (address) — Principal executive offices
  • CALDEROME INC (company) — Former company name

FAQ

What specific financial results or operational updates are detailed in this 8-K filing?

The provided excerpt of the 8-K filing does not contain specific financial figures or operational details; it only indicates that the report pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.

When was the earliest event reported in this Form 8-K?

The earliest event reported in this Form 8-K was on August 6, 2025.

What is Veracyte, Inc.'s state of incorporation?

Veracyte, Inc. is incorporated in Delaware.

What is Veracyte, Inc.'s principal executive office address?

Veracyte, Inc.'s principal executive office is located at 6000 Shoreline Court, Suite 300, South San Francisco, California 94080.

Was Veracyte, Inc. previously known by another name?

Yes, Veracyte, Inc. was formerly known as CALDEROME INC, with a date of name change on December 19, 2006.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding VERACYTE, INC. (VCYT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.